The Papillon is a petite and finely boned toy dog, distinguished by its large, highly feathered ears that resemble butterflies—hence its French name meaning "butterfly." Recognised in the UK Kennel Club's toy group, Papillons make affectionate companions suited to diverse lifestyles.
These bright and intelligent dogs are quick learners but high-energy, requiring ample physical exercise and mental stimulation. Their moderate shedding is balanced by grooming needs that can be considered moderate to high maintenance.
While Papillons typically enjoy a good lifespan of 13 to 15 years, like many purebred dogs, they can be prone to hereditary health conditions that are passed from parents to puppies. One such ailment is neuroaxonal dystrophy (NAD), a progressive neurodegenerative disorder identifiable through DNA testing, which helps breeders avoid passing this condition onto litters.
Neuroaxonal dystrophy is a rare, inherited disorder affecting the central nervous system, caused by a mutation in the PLA2G6 gene. This mutation leads to swelling of nerve axons, causing progressive neurological dysfunction, particularly in the cerebellum. Symptoms typically begin in puppies between 2 and 3 months old.
Initial signs include a wobbly or unusual gait (ataxia), intention tremors during movements, weakness, incoordination, and head tremors. As the disease progresses—usually by six months of age—affected dogs may experience inability to stand or walk, difficulties with eating and swallowing, vision problems including blindness and strabismus, and sometimes deafness.
Unfortunately, there is no cure or effective treatment for NAD, and affected dogs usually face a poor quality of life, often necessitating humane euthanasia.
NAD follows an autosomal recessive inheritance pattern, meaning a dog must inherit two copies of the mutated gene (one from each parent) to develop the disease. Dogs with only one copy are carriers who do not show symptoms but can pass the mutated gene on to their offspring.
Knowing the genetic status of parent dogs allows breeders to predict the health risks of litters:
DNA testing is the gold standard to identify carriers and affected individuals. In the UK, testing can be performed via a veterinary appointment where a cheek swab or blood sample is collected and sent to approved genetic laboratories.
Test results classify dogs as clear (normal gene), carrier (one mutated gene), or affected (two mutated genes). Responsible Papillon breeders use these results to plan matings that prevent producing affected puppies, ensuring healthier litters.
Recommended breeding strategies include mating clear dogs together or clear with carriers, avoiding carrier-to-carrier pairings. This approach gradually reduces the incidence of NAD in the breed.
For prospective Papillon owners looking to find a Papillon puppy, seeking out breeders who screen for hereditary disorders like NAD ensures healthier puppies and supports ethical breeding. DNA testing backed by the UK Kennel Club forms part of best practices to maintain the breed’s wellbeing.
Should unexpected neurological symptoms develop in young Papillons, consulting a vet promptly can allow for early diagnosis and informed care decisions, even though treatment options remain limited.
Neuroaxonal dystrophy in Papillon dogs is a serious, inherited neurological condition manifesting early in life and leading to progressive neurological decline. The UK veterinary community in 2025 strongly endorses DNA testing to identify carriers and affected dogs, enabling responsible breeding that protects future generations.
Understanding the inheritance patterns and utilising genetic testing helps breeders and owners make informed choices, supporting the health and longevity of this charming toy breed.